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ABSTRACT  The proteoglycans and glycosaminoglycans synthesized  by embryonic mouse sali- 
vary glands during  normal  morphogenesis  and  in the  presence  of fl-xyloside,  an  inhibitor of 
branching  morphogenesis,  have  been  partially characterized. Control  and p-nitrophenyl-fl-D- 
xyloside-treated  salivary  rudiments  synthesize  proteoglycans  that  are  qualitatively  similar, 
based on mobility on Sepharose CL-4B under dissociative  conditions  and glycosaminoglycan 
composition.  However,  fl-xyloside  inhibits  total  proteoglycan-associated  glycosaminoglycan 
synthesis  by 50%, and also stimulates synthesis of large amounts of free chondroitin  (dermatan) 
sulfate. This free glycosaminoglycan  accounts for the threefold stimulation  of total glycosami- 
noglycan synthesis  in fl-xyloside-treated  cultures. Several observations suggest that the disrup- 
tion of proteoglycan synthesis  rather than the presence of large amounts of free glycosamino- 
glycan is responsible for the inhibition of branching morphogenesis.  (a) We have been unable 
to  inhibit  branching  activity  by  adding  large  amounts  of  chondroitin  (dermatan)  sulfate, 
extracted  from fl-xyloside-treated  cultures,  to  the  medium  of salivary  rudiments  undergoing 
morphogenesis.  (b)  In the range of 0.1-0.4  mM fl-xyloside,  the dose-dependent  inhibition  of 
branching  morphogenesis  is directly correlated with the inhibition  of proteoglycan synthesis. 
The stimulation of free glycosaminoglycan synthesis  is independent of dose in this range, since 
stimulation  is  maximal  even  at  the  lowest  concentration  used,  0.1  mM.  The  data  strongly 
suggest  that  the  inhibition  of  branching  morphogenesis  is  caused  by  the  disruption  of 
proteoglycan synthesis  in fl-xyloside-treated  salivary  glands. 
Epithelial-mesenchymal interactions are required for the de- 
velopment of many diverse  organ  systems.  The  tissues  are 
separated by an extraceUular matrix, suggesting that develop- 
mental events might be mediated by such extracellular mac- 
romolecules as collagens (7, 28),  proteoglycans (12,  33),  and 
glycoproteins (7,  32). Recently, attention has focused on the 
role of the extraceUular matrix and the basal lamina, a zone of 
extraceUular  material  having  a  characteristic  ultrastructural 
organization, in tissue interactions. 
Development of the  embryonic salivary gland  provides a 
useful model system for studying the role of proteoglycans in 
epithelial-mesenchymal interactions.  The  multilobular  mor- 
phology of salivary glands is established by branching mor- 
phogenesis, repetitive budding, and folding of the epithelium. 
Although these shape changes are generated by forces within 
the epithelial cells themselves (29), interaction with the mes- 
enchyme is required for branching morphogenesis. Indeed, the 
pattern of epithelial morphogenesis appears to be regulated by 
the mesenchyme (21). The two tissues are separated by a basal 
lamina that contains abundant glycosaminoglycan (5), presum- 
ably as proteoglycan. Integrity of the basal lamina is required 
for maintenance of lobular morphology of the salivary rudi- 
ments (1). Furthermore, turnover of basal laminar glycosami- 
noglycan correlates with branching activity of the epithelium 
(2). These observations strongly implicate proteoglycans in the 
process of branching morphogenesis. 
One  approach  to  studying  the  role  of proteoglycans  in 
branching morphogenesis is to perturb normal biosynthesis of 
the molecules. Synthesis of the xylose-linked classes of glycos- 
aminoglycans, which include  chondroitin  sulfates,  dermatan 
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tion of certain serine residues in the proteoglycan core proteins. 
Two  galactose  residues  are  sequentially  transferred  to  each 
xylosylated  serine,  and  glycosaminoglycan  chains  are  then 
formed on these linkage regions by addition of the appropriate 
monosaccharides.  Exogenously  added fl-n-xylosides can  dis- 
rupt proteoglycan biosynthesis by competing with the endog- 
enous  substrate,  xylosylated  core protein,  at  the level  of the 
first  galactosyltransferase,  thereby  initiating  the  synthesis of 
free  glycosaminoglycan  chains.  Both  the  fl-anomer  and  the 
xylose configuration are required,  reflecting specificity of the 
enzyme (9).  Beta-xylosides stimulate total glycosaminoglycan 
synthesis in chondrocytes (19); glial, neuroblastoma,  and hep- 
atoma cells (26); and normal and transformed fibroblasts (9), 
suggesting that synthesis is normally limited by core protein in 
these systems. A  concomitant decrease in proteoglycan synthe- 
sis has been reported for fl-xyloside-treated chondrocytes (18, 
25).  We have exploited these characteristics of fl-xylosides to 
investigate  the  role  of proteoglycan  synthesis  in  branching 
morphogenesis. 
Branching  morphogenesis  of  embryonic  mouse  salivary 
glands is inhibited severely, but reversibly, by p-nitrophenyl- 
fl-n-xylopyranoside  (33).  The  degree  of  inhibition  is  dose- 
dependent,  and  similar  concentrations  of a-xyloside  do  not 
alter  branching  activity  of the  epithelium.  Synthesis of total 
sulfated glycosaminoglycan is stimulated threefold in fl-xylo- 
side-treated glands.  These observations suggest that  the inhi- 
bition of branching morphogenesis results from the effects of 
competition  of fl-xyloside  with  endogenous  substrate,  core 
protein,  at  the  level  of the  first  galactosyltransferase  in  the 
biosynthetic  pathway.  The  present  study  demonstrates  that 
synthesis of proteoglycan-associated glycosaminoglycan is in- 
hibited,  and free glycosaminoglycan synthesis is dramatically 
stimulated in B-xyloside-treated glands. Dose-response studies 
suggest  that  inhibition  of  branching  morphogenesis  results 
from inhibition of proteoglycan-associated glycosaminoglycan 
synthesis, rather than from stimulation of free glycosaminogly- 
can synthesis. 
MATERIALS  AND  METHODS 
Materials:  The xylose derivative  p-nitrophenyl-fl-D-xylopyranoside,  a 
product of Koch-Light Laboratories,  was purchased  from Research  Products 
International  Corp. (Mt. Prospect, IL). Grade I guanidine hydrochloride (Sigma 
Chemical  Co., St. Louis, MO) was used in the extraction and elntion buffers. 
Practical grade guanidine hydrochloride (Sigma Chemical Co.) was purified with 
activated charcoal (3) and used in the dialysis buffer. Benzamidine hydrochloride, 
6-aminohexanoic  acid, sodium EDTA,  whale and shark cartilage chondroitin 
sulfate, heparm, Sephadex  G-50, and Sepharose  CL-4B were purchased  from 
Sigma Chemical Co. Butyl nitrite was purchased from Eastman Laboratory and 
Specialty Chemicals,  Eastman  Kodak Co.,  Rochester,  NY.  Carrier-free  [aSS]- 
sulfuric acid was obtained from ICN Chemical and Isotope Division (ICN K & 
K  Laboratories  Inc.,  Plainview,  NY).  Pronase  (45,000 proteolytic  U/g) was 
purchased from Calbiochem-Behring Corp., American Hoechst Corp., San Diego, 
CA), and chondroitinase  ABC from Miles Laboratories Inc. (Research Products 
Div., Elkhart, IN). 
Organ  Culture:  Pregnant CD-I outbred albino mice (Charles River 
Breeding Laboratories, Inc., Wilmington, MA) were sacrificed by cervical dislo- 
cation at 13 d of gestation, counted from day 0 at discovery of the vaginal plug. 
Embryos were removed and transferred to Hanks' balanced salt solution. Under 
sterile conditions, salivary glands were dissected from the embryos. Organs were 
cultured  in a modified Ham's Fl2 medium (27) containing 2X amino acids and 
pyruvate, antibiotics, and 10% fetal calf serum (Gibeo Laboratories, Gibco Div., 
Grand Island, NY). Cultures were maintained  at 37°C in a humidified  atmo- 
sphere of 5%  CO2 in air.  For morphoganetic  studies,  organ  rudiments  were 
cultured on Grobstein organ culture assemblies (10) as described previously (33), 
and the living rudiments were photographed daily. 
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Labeling and Extraction of Proteoglycan:  Pieces of tissue con- 
sisting of the submandibular and subLingual glands together with the associated 
condensed mesenchyme (as in Fig. I) were grown in submerged culture in Falcon 
plastic  culture  dishes  (Bocton, Dickinson  & Co.,  Oxnard,  CA). The salivary 
rudiments were culture.d for 48 h in control medium or in medium containing 
I/-xyloside. Media were then replaced with serum-free Fl2 containing the appro- 
priate concentration  of ~-xyloside and 50 ~Ci [asS]-solfuric acid/ml medium. 
Serum-free  medium enhances incorporation  of labeled  precursor  but has no 
discernible effects on branching morphoganesis during the labeling period. After 
I0 h  of incubation  with label; tissue, medium,  and one Hanks' balanced  salt 
solution rinse of  the culture dishes were pooled in siliconized tubes, Samples were 
stored at -20°C. 
Proteoglycan  was extracted  by incubating  the samples for 24 h  at 4°C in 
buffer A (4 M guamdine.HCl, 0.1  M 6-aminohexanoic  acid,  10 mM sodium 
EDTA,  5 mM benzamidine.HCl, and 0.5  M  sodium  acetate,  pH  5.8  [11]). 
Insoluble material  was removed by centrifugation  at  1,000 g for 10 min. The 
pellet was reextracted for 24 h, and centrifuged again. The two supematants were 
combined,  vortexed,  and divided  into two equal  aliquots.  One aliquot  was 
chromatographed on  Sepharose  CL-4B  immediately,  whereas  the other was 
digested with pronase before chromatography. 
Column Chromatography:  Samples were concentrated by uhrafil- 
tration with an Amicon PM 10 falter (Amicon Corp. Scientific Sys. Div., Danvers, 
MA) and dialyzed against buffer A containing 0.1 M sodium sulfate. Samples 
were applied to a Sepharose CL-4B column 020 cm ×  1.5 cm) equilibrated with 
buffer A containing 0.1 M sodium sulfate and adjusted to pH 7.0. Aliquots of 
each  fraction  were  dissolved  in  an  aqueous  cocktail  and  radioactivity  was 
measured  with a  Packard  Tricarb  liquid  scintillation  spectrometer  (Packard 
Instrument Co., Inc., United Technologies, Downers Grove, IL). 
Pronase Digestion:  Aliquotsoftheguanidine.HClextractforpronase 
digestion were concentrated by ultrafiltratinn  as above, then dialyzed against 0.2 
M Tris- HCI, pH 8.0. Samples were digested with pronase as described previously 
(33). Trichloroacetic  acid  was  added (to  5%)  to  the  digested  samples  and, 
following incubation at 0°C for 1 h, they were centrifuged at 2,000 g for 10 min. 
The superuatant  was concentrated in a Speed Vac Concentrator (Savant Instru- 
ments, Inc., Hicksville, NY), dialyzed against buffer A containing 0.1 M sodium 
sulfate, and chromatographer as above. 
Chondroitinase  ABC and Nitrous  Acid Digestion:  Seph- 
arose  CL-4B peaks  were treated with chondroitinase  ABC, which selectively 
degrades  chondroitin-4-sulfate,  chondroitm-6-sulfate,  and  dermatan  sulfate. 
These glycosaminoglycan classes are referred to collectively as chondroitin (der- 
matan)  sulfate  throughout this  paper.  Fractions  in each peak  were  pooled, 
lyophilized, resnspended,  and dialyzed against 0.01 M Tris.HCI, pH 8.0, and 
digested with chondroitinase  ABC (final concentration  0.15 U/ml) for 24 h at 
25°C  (23). Commercially  obtained chondroitin  sulfate controls were digested 
simultaneously  with labeled  samples  to  confirm enzyme  actiyity.  Digestion 
products were separated from chondroitinase ABC-insensitive material by chro- 
matography on Sephadex G-50 columns. LyophiLized  samples were dissolved in 
ehition buffer (0.1 M ammonium acetate  in 20% ethanol)  and applied  to the 
columns (6). Aliquots of the Sephadex G-50 fractions were dried at 50°C and 
radioactivity was determined. 
The chondroitinase  ABC-insensitive material  was then treated  with nitrous 
acid  to  selectively degrade the N-sulfated  glycosaminoglycans,  heparm,  and 
heparan sulfate  (4,  6).  The  Sephadex  G-50  excluded  fractions  were pooled, 
lyophiLized, redissolved  in water,  and digested  as described  previonsly  (33). 
Commercially obtained heparin samples were treated simultaneously with labeled 
samples.  Digested  samples were lyophilized,  dissolved  in elution  buffer,  and 
rechromatographed  on Sephadex G-50 columns to separate digestion products 
from nitrous acid-insensitive material. 
Preparation  of Glycosaminoglycan  Fractions:  Free glycos- 
aminoglycan synthesized by salivary glands treated with 0.5 mM//-xyloside was 
prepared for addition to the culture medium of living rudiments. Sepharose CL- 
4B fractions from the glycosaminoglycan peak were pooled and dialyzed against 
four changes  of 10% F12  over 3 d.  Likewise, an equal volume  of the 4  M 
guanidine.HC1  elution buffer was dialyzed against 10% F12 to provide a buffer 
control The dialyzates  were lyophiLized and weighed, before being added to 
culture medium. 
[lectron Microscopy:  Day 13 salivary glands were cultured on Mil- 
lipore falters (Millipore/Continental  Water Systems, Bedford, MA) in Grobstein 
dishes or on Falcon plastic petri dishes. Rudiments were cultured  for 48 h in 
control medium or medium containing 0.5 mM a- or B-xyloside; fixed with 2.5% 
glutaraldehyde  in 75 mM phosphate buffer, pH 7.2; postf'Lxed  with 1% OsO4 in 
75 mM phosphate buffer containing  180 mM sucrose, pH 7.2; dehydrated; and 
embedded in Epon-Araldite.  Sections were stained with uranyl acetate and lead 
citrate, and examined with a Philips 201 electron microscope. RESULTS 
Branching Morphogenesis  of Salivary Glands 
In  Vitro 
Salivary rudiments dissected from 13-d mouse embryos in- 
crease substantially in size during  a  48-h culture period (Fig. 
1  A and B). New lobes are formed by repetitive branching and 
folding  of the  epithelium.  Like  control  rudiments,  salivary 
glands  cultured  in  the  presence  of  0.5-1.0  mM  fl-xyloside 
continue to grow, accumulating total protein per rudiment that 
is 85-100% of the protein accumulation in control glands. The 
ultrastructural  organization  of the  epithelium  and  the  sur- 
rounding mesenchyme appears normal in the treated rudiments 
(Fig. 2). However, few new lobes are formed (Fig.  1 C and D). 
Thus,  branching  morphogenesis  is  severely inhibited  by  0.5 
mM fl-xyloside. 
Sepharose CL-4B Profiles of Proteoglycans and 
Glycosaminoglycans  Synthesized by Salivary 
Glands In Vitro 
From  both  control  and  fl-xyloside-treated  cultures,  three 
major size classes of sulfated macromolecules are resolved by 
Sepharose  CL-4B  chromatography  under  dissociative  condi- 
tions (Fig. 3). Although the peaks contain different proportions 
of radioactivity in the two sample types, the comparable peaks 
from control and fl-xyloside-treated cultures have similar elu- 
tion volumes. Both the largest size class (PG-1), which elutes 
at  the  void  volume,  and  the  intermediate  size  class  (PG-2) 
contain sulfated proteoglycan. All of the radioactivity in PG-1 
and PG-2, whether from control or fl-xyloside-treated cultures, 
is shifted to a peak with much larger elution volume in pronase- 
digested  samples (not shown).  Because the smallest size class 
of sulfated macromolecules from control cultures, peak-3, has 
an  elution  volume  similar  to  that  of the  pronase-liberated 
glycosaminoglycan chains,  comparison of the CL-4B profiles 
of untreated  and  pronase-digested  samples  is  not  useful  for 
distinguishing whether peak-3 contains protein-associated gly- 
FIGURE  1  Branching  morphogenesis  of  control  and  `8-xyloside- 
treated salivary glands. A  pair of 13-d salivary glands (Sin,  subman- 
dibular;  Sl, sublingual)  cultured  in control medium  is shown at 24 
h  (A)  and  48  h  (B)  of  culture.  Rudiments  cultured  in  0.5  mM ,8- 
xyloside are shown at 24 h  (C)  and 48 h  (D)  of culture. Although 
both pairs of glands undergo substantial increase in size, branching 
activity of the ,8-xyloside-treated rudiments is inhibited, x  26. 
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FIGURE  2  Transmission  electron micrograph  of an epithelial-mes- 
enchymal  interface  region  of  a  rudiment  cultured  in  0.5  mM  fl- 
xyloside for 48 h  (x 7,700). The basal lamina (BL) is continuous over 
the epithelial (E) surface. Abundant fibrillar collagen (C)  is seen in 
the extracellular matrix surrounding mesenchymal cells (M). 
cosaminoglycan. Therefore, fractions containing control peak- 
3 were pooled, digested with pronase, and rechromatographed 
on  CL-4B.  The  elution  volume  is  not  altered  by  pronase 
digestion,  suggesting  that  peak-3  contains  either  free glycos- 
aminoglycan or small proteoglycan molecules with only a few 
glycosaminoglycan chains per molecule. Likewise, the elution 
volume of peak-3  from fl-xyloside-treated glands is identical 
for both untreated and pronase-digested samples (not shown), 
suggesting  that  peak-3  contains  predominantly  glycosamino- 
glycan chains that have been initiated on the fl-xyloside mol- 
ecules. 
The Sepharose CL-4B profdes in Fig. 3 also demonstrate the 
quantitative  effects  of  0.5  mM  fl-xyloside  on  synthesis  of 
glycosaminoglycan  in  salivary  rudiments.  Synthesis  of total 
proteoglycan-associated glycosaminoglycan, PG-1  plus PG-2, 
is  inhibited  50%  in  treated  cultures.  However,  such  cultures 
accumulate  large  amounts  of newly  synthesized  free  glycos- 
aminoglycan, which presumably is initiated on the fl-xyloside 
molecules.  The large amounts  of free glycosaminoglycan ac- 
count  for a  threefold  stimulation  of total sulfated glycosami- 
noglycan synthesis. This value is in agreement with the three- 
fold stimulation  measured  by other procedures  and  reported 
previously (33). 
Beta-xylosides have been  reported to decrease  the number 
and  average  chain  length  of glycosaminoglycans  associated 
with  core  protein  in  several  systems  (15,  17,  18,  20).  Beta- 
xyloside does not appreciably alter the elution volume on CL- 
4B of the major size classes of sulfated macromolecules: PG-1 
is not removed from the excluded to included fractions and the 
broad PG-2 peak, although overlapping with the free glycos- 
aminoglycan  peak,  has  an  elution  volume similar  to  that  of 
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PG-2  from  control  cultures.  However,  the  possibility  that 
treated  rudiments  synthesize  proteoglycans  with  fewer  or 
shorter glycosaminoglycan chains cannot be ruled out without 
direct comparison of the glycosaminoglycan moieties of these 
proteoglycans. 
Chondroitinase ABC and Nitrous Acid 
Sensitivity of Glycosaminoglycans Synthesized 
by Cultured Salivary Glands 
In order to further characterize the sulfated glycosaminogly- 
cans produced by embryonic salivary glands in culture, pooled 
fractions from each of  the Sepharose CL-4B peaks were assayed 
for sensitivity to chondroitinase ABC and nitrous acid degra- 
dation.  Chondroitinase  ABC  is  specific  for the  chondroitin 
sulfates (chondroitin-4-sulfate, chondroitin-6-sulfate, and der- 
matan sulfate), whereas nitrous acid degrades heparan sulfate 
and heparin. Chondroitin (dermatan) sulfate accounts for most 
of the labeled glycosaminoglycan in PG-1.88% of the sulfated 
material, either from control or fl-xyloside-treated cultures, is 
sensitive to chondroitinase ABC digestion (Table I). Peak PG- 
2  contains both chondroitin (dermatan)  sulfate  and heparan 
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Sensitivity of 5epharose CL-4B Proteoglycan Peaks to 
Chondroitinase ABC and Nitrous Acid Digestion 
PG-1  PG-2 
chondroitin (dermatan)  sulfate peak is unique to fl-xyloside- 
treated cultures strongly suggest that its synthesis is initiated 
on the exogenously added fl-xyloside, rather than on the en- 
dogenous substrate, core protein. 
Control  fl-Xyloside  Control  fl-Xyloside 
%  % 
Chondroitinase-ABC-  88*  88  74  67 
sensitive 
Nitrous-acid-sensitive  2  ND  24  22 
Chondroitinase-ABC-  10  ND  2  11 
and nitrous-acid- 
insensitive 
* Numbers represent percent of total counts per min 35S in sample. 
ND, not done. 
TABLE  II 
Sensitivity of Sepharose CL-4B Peak 3 to Chondroitinase ABC 
and Nitrous Acid Digestion 
Control  ,8-Xyloside 
cpm/ rudiment  %  cpm/ rudiment  % 
Chondroitinase-ABC-  30  14"  4713  97 
sensitive 
Nitrous-acid  -sensitive  186  84  139  3 
Chondroitinase-ABC- and  6  3  11  <1 
nitrous-acid-insensitive 
* Numbers represent percent of total counts per min 3SS in sample. 
sulfate,  suggesting that this size class includes more than one 
species of proteoglycan. Chondroitinase ABC degrades 74% of 
the labeled glycosaminoglycan in PG-2 from control cultures 
and  67%  from fl-xyloside-treated  cultures.  Sensitivity  of the 
sulfated  glycosaminoglycan in  PG-2  to  nitrous  acid  is  also 
similar:  24%  (control  cultures)  and  22%  (fl-xyloside-treated 
cultures).  Thus,  based  on sensitivity  to chondroitinase  ABC 
and  nitrous  acid  degradation,  fl-xyloside  does  not  alter  the 
glycosaminoglycan composition of PG-1 and PG-2. 
The sulfated glycosaminoglycan in peak-3 from control cul- 
tures  is  predominantly  heparan  sulfate.  While  84%  of the 
labeled material is sensitive to degradation with nitrous acid, 
only 14% is digested by chondroitinase ABC (Table  II). It is 
not clear whether this material, which appears to be either free 
glycosaminoglycan or proteoglycan with  only a  few  glycos- 
aminoglycan chains per molecule, occurs normally in embry- 
onic salivary glands in vivo, occurs only in cultured rudiments, 
or results from the extraction procedures.  However, heparan 
sulfate with little or no associated protein has been reported in 
other systems,  such  as  embryonic lung fibroblasts  (34),  3T3 
ceils (14), and PYS-2 cells (22). 
In contrast to control peak-3, only 3% of the sulfated glycos- 
aminoglycan in peak-3 from B-xyloside-treated cultures is sen- 
sitive to nitrous acid degradation (Table  II). However, 3% of 
the large peak represents  139 cpm [asS]-heparan sulfate/rudi- 
ment,  a  value  similar  to the  186  cpm  [35S]-heparan  sulfate/ 
rudiment in peak-3 from control cultures (Table II). The data 
suggest that  this  free heparan  sulfate  is neither  dramatically 
stimulated nor inhibited in the presence of fl-xyloside. 
The remainder of peak-3 in fl-xyloside-treated cultures, 97%, 
is sensitive to digestion with chondroitinase ABC (Table  II). 
This huge pool of free chondroitin (dermatan) sulfate accounts 
for 82% of the total sulfated glycosaminoglycan accumulated 
during the labeling period (data averaged from three experi- 
ments). The observations that the elution volume on CL-4B of 
peak-3 is not altered by pronase digestion and that this large 
Effect of Free Glycosaminoglycan  on Branching 
Morphogenesis of Cultured Salivary Glands 
Since fl-xyloside inhibits  synthesis  of proteoglycan-associ- 
ated glycosaminoglycan as well as initiating synthesis of large 
amounts of free glycosaminoglycan, it is of interest to determine 
whether either of these  effects is  related  to the inhibition  of 
branching morphogenesis. The effect of free glycosaminogly- 
can on branching morphogenesis was tested by culturing sali- 
vary rudiments in the presence of exogenously added glycos- 
aminoglycans, obtained either from fl-xyloside-treated cultures 
or as commercially available chondroitin sulfate. Chondroitin 
(dermatan) sulfate synthesized by salivary glands treated with 
0.5 mM fl-xyloside was prepared as described in Materials and 
Methods.  An  identical  volume  of the  guanidine  buffer  was 
prepared in the same way, to provide a buffer control. Day 13 
salivary glands were cultured in control medium,  or medium 
containing  various  concentrations  of the  dialyzed  buffer or 
glycosaminoglycan or commercially obtained chondroitin sul- 
fate. Media were changed daffy. 
The extent of branching morphogenesis after 48 h of culture 
is  shown  in  Fig.  4.  In the  presence  of 0.5  mM  B-xyloside, 
branching activity is severely inhibited.  We have been unable 
to significantly alter branching activity by adding 0.51-1.27 mg 
of the  prepared  free  glycosaminoglycan fractions  per  ml  of 
medium,  although this  represents  approximately two to five 
times the amount of free chondroitin (dermatan) sulfate accu- 
mulated  over  10  h  in  cultures  chronically  treated  with  fl- 
xyloside. The appearance  of such glands is indistinguishable 
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FIGURE  4  The effects of/~-xyloside and free glycosaminoglycan on 
branching  morphogenesis  of  salivary  glands.  Salivary  rudiments 
were cultured in control medium or medium containing fl-xyloside 
(0.5  mM);  free glycosaminoglycan isolated from/3-xyloside-treated 
cultures  (0.51 or 1.27 mg/ml);  buffer alone, prepared identically to 
the free glycosaminoglycan; or commercially obtained chondroitin 
sulfate from cartilage (1.0 mg/ml). The extent of branching morpho- 
genesis after 48 h  in culture, i.e., the number of lobes per subman- 
dibular gland, is expressed as percent of control.  Data is averaged 
from two experiments, with five to nine rudiments per experimental 
condition. Error bars indicate standard error of the mean. 
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glycosaminoglycan has been prepared from the CL-4B peak 
and therefore contains other components of similar molecular 
size, such as many proteins. The final concentration of glycos- 
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FIGURE  5  Correlation of the inhibition of branching morphogene- 
sis with concentration of/Y-xyloside. Extent of branching morpho- 
genesis  is  indicated by  the  number of  lobes  per submandibular 
gland at 24, 48, and 72 h of culture. Error bars indicate standard error 
of the mean (n =  23-26). 
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aminoglycan in the medium is thus <0.51-1.27 mg/ml. How- 
ever, even 1.0 mg/ml of cartilage chondroitin sulfate does not 
alter branching activity. Together, these data suggest that the 
inhibition  of branching morphogenesis in fl-xyloside-treated 
salivary glands  is not  caused  by the  large  amounts of free 
chondroitin  (dermatan) sulfate that accumulate in these cul- 
tures. 
Effects of Increasing Doses of ~-Xyloside on 
Proteoglycan Synthesis, Free Glycosaminoglycan 
Synthesis, and Branching Morphogenesis 
In order to determine whether the inhibition of branching 
morphogenesis is linked to the inhibition of proteoglycan syn- 
thesis,  the responses to varying doses of ~8-xyloside were ex- 
amined.  Salivary glands cultured in control medium for 3 d 
undergo extensive branching activity, resulting in the formation 
of many new lobes (Fig.  5). When cultured in 0.1-0.4 mM/~- 
xyloside, a dose-dependent inhibition of morphogenesis is ob- 
served. The effects of the same concentrations on glycosami- 
noglycan synthesis were determined by culturing the rudiments 
for 48 h in control medium or medium containing 0.1-0.4 mM 
fl-xyloside and labeling with [~S]-sulfate for 10 h.  Sepharose 
CL-4B profiles of the sulfated macromolecules are shown in 
Fig.  6.  The inhibition  of proteoglycan-associated glycosami- 
noglycan synthesis is directly related to the concentration of 
tg-xyloside.  However, stimulation  of free glycosaminoglycan 
synthesis is not dose-dependent over this range of fl-xyloside 
concentrations.  Rather,  free  chondroitin  (dermatan)  sulfate 
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FIGURE 6  Sepharose CL-4B profiles of proteoglycan and glycosaminoglycan  extracted from control and ,8-xyloside-treated  cultures. 
Guanidine. HCI extracts from control cultures (©) elute as three major size classes: PG-1, PG-2, and a very small peak-3. Profiles of 
extracts from cultures treated with fl-xyloside at concentrations of 0.1  mM  (A), 0.2 mM  (E), 0.3 mM  (O), and 0.4 mM  (closed 
arrowheads) are  shown. The  inhibition of  proteoglycan associated  glycosaminoglycan synthesis  (PG-1 and  PG-2)  is  directly 
correlated with concentration of /3-xyloside.  Inset  shows the entire free glycosaminoglycan peak  (peak-3).  Size of  peak-3  is 
independent of ,8-xyloside concentration between 0.1 and 0.4 mM. 
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tested, 0.1 mM fl-xyloside. 
DISCUSSION 
Previously we had demonstrated that branching morphogenesis 
of embryonic salivary glands is inhibited by fl-xyloside (33). 
The inhibition  is dose-dependent, specific for the fl-anomer, 
and reversible, and is correlated with  a  stimulation of total 
glycosaminoglycan synthesis. In the present study, the effects 
of fl-xyloside on proteoglycan and glycosaminoglycan synthe- 
sis, and the relationship between these effects and inhibition of 
branching morphogenesis have been determined. 
Partial characterization, on the basis of mobility on Sepha- 
rose CL-4B and sensitivity to degradation with chondroitinase 
ABC and nitrous acid, does not resolve qualitative differences 
in the  proteoglycans synthesized by control and/~-xyloside- 
treated rudiments.  However, quantitatively, synthesis of total 
proteoglycan-associated glycosaminoglycan is inhibited ~50% 
in salivary glands treated chronically with 0.5 mM fl-xyloside. 
In addition to inhibiting proteoglycan-associated glycosami- 
noglycan  synthesis,  fl-xyloside  stimulates  synthesis  of large 
amounts of free chondroitin (dermatan) sulfate. It is interesting 
that heparan sulfate synthesis is not stimulated in the presence 
of fl-xyloside. The galactosyl-galactosyl-xylosyl-serine linkage 
region is common to heparin and heparan sulfate and chon- 
droitin and dermatan sulfates (16, 24), suggesting that fl-xylo- 
sides  should  serve as  initiators  for synthesis  of all of these 
classes  of glycosaminoglycans. Indeed, in SV-40-transformed 
3T3 cells, fl-xyloside stimulates synthesis of both heparan and 
chondroitin  sulfates  (13).  However,  response  to  the  xylose 
derivatives varies greatly. In rat hepatocytes, fl-xyloside initi- 
ates  synthesis  of heparan  sulfate,  but  only  if core  protein 
synthesis is inhibited by cycloheximide (31).  In rat glial and 
mouse neuroblastoma ceils, synthesis of chondroitin sulfates is 
dramatically stimulated; however, as in salivary glands, hep- 
aran sulfate synthesis is not stimulated (9). Finally, rat serosal 
mast cells, which normally produce only heparin proteoglycan, 
synthesize  free glycosaminoglycan chains  that  are predomi- 
nantly chondroitin sulfates in response to fl-xyloside (30). The 
significance of the variable response to fl-xyloside in terms of 
regulation of glycosaminoglycan synthesis in these systems is 
not clear, but poses some intriguing questions. 
That the inhibition of  branching morphogenesis is not caused 
by the presence of large amounts of free chondroitin (derma- 
tan) sulfate in the fl-xyloside-treated cultures is supported by 
several  observations:  (a)  We  have  been  unable  to  inhibit 
branching morphogenesis of salivary rudiments by adding to 
the  medium  large  amounts  of free  chondroitin  (dermatan) 
sulfate extracted from fl-xyloside-treated cultures. (b) Similarly, 
addition of 1.0 mg/ml commercially obtained cartilage chon- 
droitin sulfate fails to inhibit branching activity. (c) Over the 
range of 0.1-0.4  mM fl-xyloside, there is no correlation be- 
tween  the  inhibition  of branching  morphogenesis  and  the 
synthesis of free chondroitin (dermatan) sulfate. That is, syn- 
thesis is already maximally stimulated at the lowest dose, 0.1 
raM, where morphogenesis is only minimally affected. 
The present study instead suggests  that fl-xyloside inhibits 
morphogenesis by inhibiting synthesis of proteoglycan-associ- 
ated glycosaminoglycan. The data demonstrate that the inhi- 
bition of proteoglycan-associated glycosaminoglycan synthesis 
by 0.1-0.4  mM fl-xyloside is dose-dependent,  and correlates 
directly with a dose-dependent inhibition of branching mor- 
phogenesis. The biosynthetic inhibition could be accounted for 
by synthesis of decreased numbers of proteoglycan molecules 
THOMPSON 
or molecules with fewer or shorter glycosaminoglycan chains. 
Such effects have been reported for fl-xyloside-treated chon- 
drocytes, which synthesize proteoglycan with both fewer and 
shorter glycosaminoglycan chains (17).  Further characteriza- 
tion of the proteoglycans synthesized by salivary rudiments in 
the  presence  of ~8-xyloside will  be  necessary to  distinguish 
between these possibilitie  s  . Nevertheless, the present study does 
establish that disruption of proteoglycan synthesis results in 
inhibition of branching morphogenesis. 
The dynamic nature of glycosaminoglycan in the basal lam- 
inae of embryonic salivary glands has been demonstrated by 
Berntield and Baneoee (2). Rates of turnover of basal laminar 
glycosaminoglycan, presumably as proteoglycan, correlate with 
actively branching and morphogenetically quiescent regions of 
the epithelium. Both synthesis of basal laminar glycosamino- 
glycan by the epithelium and degradation by the mesenchyme 
contribute  to  turnover  rates.  The  same  investigators  have 
shown that the integrity of the chondroitin sulfate-rich basal 
lamina is required for maintenance of lobular morphology in 
salivary rudiments (1,  5).  They suggest that accumulation of 
the epithelially produced basal laminar glycosaminoglycan in 
the interlobular clefts, where rates of synthesis exceed rates of 
degradation, might contribute to stabilization of lobular mor- 
phology, whereas the relatively rapid degradation at the distal 
regions of lobes is necessary to accommodate growth of the 
epithelium  (2).  Both  stabilization  of interlobular  clefts  and 
growth of the epithelial lobes are required for ongoing branch- 
ing activity. It is therefore reasonable to ask whether fl-xyloside, 
at concentrations that inhibit synthesis of proteoglycan-asso- 
ciated glycosaminoglycan, also affect the ultrastructural orga- 
nization of the basal lamina. Using standard glutaraldehyde/ 
osmium fixation, we have been unable to detect any obvious 
differences in  the  basal  laminae  of control  and  fl-xyloside- 
treated rudiments (note the normal appearance of the basal 
lamina  in  Fig.  2).  However,  it  should  be  emphasized  that 
normal ultrastructural appearance does not imply normal func- 
tion. It is probable that classes of macromolecules other than 
proteoglycans, such as laminin and/or type IV collagen, are 
integral components of the basal lamina. Thus, in the presence 
of 0.5 mM ~-xyloside, sufficient proteoglycan might be inserted 
into the basal lamina to maintain the normal ultrastructural 
organization, but not to support branching morphogenesis. The 
organization of anionic sites in basal laminae has been studied 
in tissues fixed in the presence of ruthenium red (5) or polyeth- 
yleneimine (8). Such approaches may be useful for distinguish- 
ing changes in the organization of proteoglycan in fl-xyloside- 
treated basal laminae. 
Although the studies linking basal laminar glycosaminogly- 
can with branching morphogenesis suggest that fl-xyloside may 
disrupt  basal  laminar  function,  it  is  also  possible  that  an 
abnormal extracellular matrix is laid down by the mesenchymal 
cells. Spooner and Faubion (28) have demonstrated that inhi- 
bition of collagen secretion in the presence of L-azetidine-2- 
carboxylic acid is correlated with both loss of interstitial col- 
lagen fibrils and inhibition of branching morphogenesis, sug- 
gesting that branching activity is dependent  on composition 
and/or organization of the mesenchymally produced matrix. It 
is also possible that the inhibition of branching morphogenesis 
in the presence of fl-xyloside results from disruption of proteo- 
glycan synthesis in both epithelial and mesenchymal ceils. 
The observation that large amounts of free glycosaminogly- 
can do not substitute for the proteoglycan-associated glycos- 
aminoglycan that mediates branching morphogenesis has im- 
portant  implications  for the  role  of proteoglycans in  tissue 
interactions. The organization of the glyeosaminoglycan chains 
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basal lamina or mesenchymal extraceUular matrix. The protein 
core itself may contribute to interactions of the proteoglycan 
with other matrix components. Further characterization of the 
proteoglycans synthesized by fl-xyloside-inhibited sahvary ru- 
diments  will  provide  insight  into  the  structural  features  of 
proteoglycans required for branching morphogenesis. 
We  are  grateful  to  Dr.  Gary  Conrad for many helpful discussions 
throughout the course of this study, to Dr. Avelina Paulsen for advice 
and assistance  with electron microscopy, to Mark  Sullens and Brad 
Stokes for cheerful and unflagging technical assistance,  and to Dana 
Custer for typing the manuscript. 
The study was supported by National Institutes of Health grant HL- 
25910 and grant  KSA-81-81  from the American Heart  Association, 
Kansas Affiliate. 
This manuscript has been submitted by H. A. Thompson in partial 
fulfillment of the requirements for the Ph.D. degree  at Kansas State 
University. 
Reprint requests should be addressed to Dr. Spooner at his address 
as given on the title page. 
Received for publication 15 September 1982, and in revised  form 4 Feb- 
ruary 1983. 
REFERENCES 
I.  Banerjce,  S.  D.,  R.  H.  Cohn,  and M.  R.  Bernfield.  1977. Basal lamina  of embryonic 
salivary epithelia: production  by the epithelium  and role in maintaining  epithelial mor- 
phology. J. Cell Biol.  73:445-463. 
2.  Bemfield, M., and S. D. Bane~jee. 1982. The turnover of basal lamina glycosaminoglycan 
correlates with epithelial morphogenesis. Dev. Biol.  90:291-305. 
3.  Brady, J. N., and R. A. Consigli. 1978. Chromatographic  separation of the polyoma virus 
proteins and renaturation  of the isolated VPI major capsid protein. Z  Virol.  27:436-442. 
4.  Cifondli, J.  A., and J,  King.  1972. The distribution  of 2-acetarmilo-2-deoxy-l~-ghicose 
resiilu  es in mammalian  heparins. Carbohydr.  Res. 2 l:  173-186. 
5.  Cohn,  R.  H.,  S.  D.  Banerjee,  and M.  R.  Bemlluld.  1977. Basal lamina  of embryonic 
salivary epithelia: nature of  glycosaminoglycan and organization of  extraceilular materials. 
Z  Cell Biol.  73:464--478. 
6.  Conrad, G. W., and G. W. Hart.  1975. Heparan sulfate biosynthesis by embryonic tissues 
and primary fibrobl~t populations.  Def. Biol.  44:253-269. 
7.  Ekblom,  P.  1981. Formation  of basement  membranes  in  the  embryonic  kidney:  an 
tmmunohistologi.cad  study. 3". Cell Biol. 91:1-10. 
8.  Essner, E., and R. M. Pino. 1982. Distribution of aninnic sites in Bruch's membrane of the 
rabbit eye. Fur. Z  Cell Biol. 27:251-255. 
9.  GaBigani, L., J. Hopwood, N. B. Schwartz, and A. Dorfman. 1975. Stimulation of synthesis 
of free  chondroltia  sulfate  chains  by  /?-o-xylosides in cultured  cells. Z  Biol.  Chem. 
250:5400-5406. 
10.  Grobstein,  C.  1956. Transrilter  induction  of tubules  in mouse metanephrogenic  mesen- 
chyme. Exp.  Cell Res.  10:424-440. 
1  I.  Hassell, J. R., P. G. Robey, H. J. Barrach, J. Wilczek, S. I. Rermard, and G. R. Martin. 
1980. Isolation of a heparan  sulfate-containing  proteoglycan from basement membrane. 
Proc. NatL Acad  Sci.  USA. 77:4494-4498. 
12.  Hayashi, A., P. K. Donahoe, G. P. Budzik, and R. L. Trelstad.  1982. Periductal and matrix 
glycosaminoglycans in rat muilerian duct development and regression. Dev. Biol.  92:16- 
26. 
13.  Johnston,  L.  S., and J.  M.  Keller.  1979. The  effect of fl-xylosides on heparan  sulfate 
synthesis by SV40-transformed Swiss mouse 3"I"3  cells. J. Biol.  Chem. 254:2575-2578. 
14.  Johnston,  L. S., K. L. Keller, and J. M. Keller. 1979. The heparan sulfates of Swiss mouse 
3T3 cells: the effect of transformation.  Biochim.  Biophys.  Acla. 583:81-94. 
15.  Kato, Y., K. Kimata, K. Ito, K. Karasawa, and S. Suzuki. 1978. Effect offl-D-xyloside and 
cycloheximide on the synthesis of two types of proteochondroitin sulfate in chick embryo 
cartilage. Z Biol.  Chem. 253:2784-2789. 
16.  Kraemer, P. M., and D. A. Smith. 1974. High molecular-weight heparan  sulfate from the 
cell surface. Biochem. Biophys.  Res. Commun. 56:423-430. 
17.  Lohmander, L. S., V. C. Hascall, and A. I. Caplan.  1979. Effects of 4-methyl umbeUiferyl- 
B-D-xylopyrannside on chondrogenesis  and  proteoglycan  synthesis in chick  limb bud 
mesenchymal cell cultures. J. Biol.  Chem. 254:10551-10561. 
18.  Lohmander,  S., K. Madsen, and A. Hinek.  1979. Secretion of proteoglycans by chondro- 
eytes: influence of colchichae, cytochalasin B, and fl-D-xyluside. Arch.  Biochem.  Biophys. 
192:148-157. 
19.  Madsen,  K.  1981. Glycosammoglycan  secretion  from  perfused  mouolayer  cultures  of 
rabbit ear chondrocyt~:  modification of xyloside effect by colchicine and cytochalasin B 
Arch. Biochem. Biophys.  211:368-374. 
20.  Mitchell, D., and T. Hardingham.  1981. The effects of cycloheximide on the biosynthesis 
and secretion of proteoglycans by chondrocytes in culture. Biochem. J.  196:521-529. 
21.  Nogawa, H., and T. Mizuno. 1981. Mesenchymal control over elongating and branching 
morphogenesis in salivary gland development. J. Embryol. Exp. Morphol. 66:209-221. 
22.  Oohira,  A.,  T.  N.  Wight,  J.  McPherson,  and  P.  Bornstein.  1982. Biochemical  and 
ultrastructural  studies of proteoheparan  sulfates synthesized by PYS-2, a basement mem- 
brane-producing  cell line. J. Cell Biol.  92:357-367. 
23.  Robinson, H. C., and A. Dorfman.  1969. The sulfation of chondroitin sulfate in embryonic 
chick cartilage epi.physes. J. BioL  Chem. 244:348-352. 
24.  Rod6n,  L.  1980. Structure  and metabohsm  of connective tissue proteogiycans.  In  The 
Biochemistry of Glycoproteins  and Proteoglycans. W. J. Lermarz, editor.  Plenum Press, 
New York 267-371. 
25.  Schwartz, N. B. 1977. Regulation of chondroitin sulfate synthesis: effect of fl-xylosides on 
synthesis of chondroitin sulfate proteoglycan, chondroitin sulfate chains, and core protein. 
J.  BioL  Chem. 252:6316~321. 
26.  Schwartz, N. B., L. Galligani,  P. L. Ho, and A. Dorfman.  1974. Stimulation of synthesis 
of free chondroitin sulfate chains by B-D-xylosides in cultured cells. Proc.  NatL Acad Sci. 
USA. 71:4047-4051. 
27.  Spooner,  B. S.  1970. The expression of differentiation  by chick embryo thyroid  in cell 
culture.  1.  Functional  and  f'me structural  stability  in mass  and  clonal  culture.  J.  Cell 
Physiol. 75:33-48. 
28.  Spooner, B. S., and J. M. Fanbion.  1980. Collagen involvement in branching morphogen- 
esis of embryonic lung and salivary gland. Dev. Biol.  77:84-102. 
29.  Spooner, B. S., and N. K. Wessells. 1972. Art analysis of salivary gland morphogenesis: 
role of cytoplasmic microfilaments and microtubules. Dev. Biol.  27:38-54. 
30.  Stevens, R. L., and K. F. Ansten. 1982. Effect of p-nitrophanyl-fl-o-xyloside on proteogly- 
can  and glycosarninoglycan synthesis in rat  serosal  mast  cell cultures.  Z  Biol.  Chem. 
257:253-259. 
31.  Sudhakaran,  P.  R.,  W.  Sinn,  and K.  von Figura.  1981. Initiation  of altered  heparan 
sulphate on fl-D-xytoside in rat hepatocytes. Hoppe-Seyler's Z. Physiol. Chem. 362:39~6. 
32.  Thesleff, I., H. J. Barrach, J. M. Foidart, A. Vaheri, R. M. Pratt, and G. R. Martin.  1981. 
Changes  in the distribution  of type IV collagen, laminin,  proteoglycan, and  fthronectin 
during mouse tooth development. Dev. BioL  81:182-192. 
33.  Thompson,  H. A., and B. S. Spooner.  1982. Iulaibition of branching  morphogenesis and 
alteration of glycosaminoglycan biosynthesis in salivary glands treated with/~-D-xyloside. 
Dev.  Biol.  89:417-424. 
34.  Vogel, K. G., and D. W. Peterson.  1981. Extracellular, surface, and intracellutar proteo- 
glycans produced by human embryo lung fihroblasts in culture (IMK-90). Z  Biol.  Chem. 
256:13235-13242. 
1450  THE  IOURNAL  OF  CELL BIOLOGY • VOLUME  96, 1983 